The mucin family of proteins: candidates as potential biomarkers for colon cancer

KE Cox, S Liu, TM Lwin, RM Hoffman, SK Batra… - Cancers, 2023 - mdpi.com
Simple Summary Colorectal cancer is the second leading cause of cancer-related deaths in
the United States with an overall 5-year survival of 65%. While there have been many …

Application of polypyrrole-based electrochemical biosensor for the early diagnosis of colorectal cancer

X Zhang, X Tan, P Wang, J Qin - Nanomaterials, 2023 - mdpi.com
Although colorectal cancer (CRC) is easy to treat surgically and can be combined with
postoperative chemotherapy, its five-year survival rate is still not optimistic. Therefore …

Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study

C Li, K Zhao, D Zhang, X Pang, H Pu, M Lei, B Fan… - BMC medicine, 2023 - Springer
Background Current prognostic prediction models of colorectal cancer (CRC) include only
the preoperative measurement of tumor markers, with their available repeated postoperative …

Mucins as potential biomarkers for early detection of cancer

SK Gautam, P Khan, G Natarajan, P Atri, A Aithal… - Cancers, 2023 - mdpi.com
Simple Summary Early cancer detection is a challenge in treating cancer patients.
Remarkably, carcinomas of the breast, lung, liver, pancreas, ovary, and colon contribute to …

[Retracted] A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta‐Analysis

X Qing, L Liu, X Mao - Computational and Mathematical …, 2022 - Wiley Online Library
Objective. To evaluate the value of combined detection of serum CA125, CA199, and HE4 in
the diagnosis of ovarian cancer. Methods. Relevant articles retrieved from PubMed, Elsevier …

[HTML][HTML] Biomarkers in Colorectal Cancer: Actual and Future Perspectives

HD Lișcu, N Verga, DI Atasiei, DC Badiu… - International Journal of …, 2024 - mdpi.com
Biomarkers in colorectal cancer (CRC) are of great interest in the current literature due to
improvements in techniques such as liquid biopsy and next-generation sequencing (NGS) …

Novel drug delivery systems in colorectal cancer: Advances and future prospects

A Awasthi, P Paul, MS Mir, SK Singh, K Dua - Pathology-Research and …, 2024 - Elsevier
Colorectal cancer (CRC) is an abnormal proliferation of cells within the colon and rectum,
leading to the formation of polyps and disruption of mucosal functions. The disease …

Predictive value of monocyte to high-density lipoprotein cholesterol ratio and tumor markers in colorectal cancer and their relationship with clinicopathological …

X Zhang, H Qin, X Tan, Y Mo, Z Li, G Huang… - World Journal of Surgical …, 2023 - Springer
Objective To evaluate the predictive value of monocyte (M) to high-density lipoprotein
cholesterol (HDL-C) ratio (MHR) and tumor markers in colorectal cancer (CRC) and their …

Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis

MI Magnusson, BA Agnarsson, JG Jonasson… - British Journal of …, 2023 - nature.com
Background The TNM system is used to assess prognosis after colorectal cancer (CRC)
diagnosis. Other prognostic factors reported include histopathological assessments of the …

Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical …

Y Tan, R Liu, J Xue, Z Feng - Cancer Medicine, 2024 - Wiley Online Library
Objective This retrospective observational study aims to develop and validate artificial
intelligence (AI) pathomics models based on pathological Hematoxylin–Eosin (HE) slides …